Setting the standard for
rigorous clinical evidence

We believe digital care must be put to the test as rigorously as traditional care. People’s mental health depends on it. That belief fuels our commitment to clinical evidence.

90+

Peer-reviewed publications

Randomized controlled trials (RCTs)

28k+

Participants across all evidence papers

All studies

Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trial

Carl et al. (2020)

Depression & Anxiety

Read Paper

You might also enjoy…

The dawn of digital medicine

What is digital medicine? Digital medicine is a subset of digital health that can be defined as automated psychological therapy.

Blog /

min read

Patients initiating pharmacotherapy are generally not receiving guideline-recommended care for insomnia and anxiety

While benzodiazepine and hypnotic medications are generally not indicated as first-line treatments for insomnia and anxiety, an alarming number of patients are being treated with these medications as the first and only treatment. Big Health recently engaged Milliman to conduct a study on treatment patterns for traditional Medicare beneficiaries with insomnia disorder and generalized anxiety...

Report

Not investing in employee mental health is a costly mistake

Investing in effective mental health care is a good human and financial decision.

Blog /

min read

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.

1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.

DOC-3046 Effective 11/2023